Skip to main content
. 2021 May 21;114(3):1148–1158. doi: 10.1093/ajcn/nqab150

TABLE 1.

Baseline characteristics of study participants1

Characteristic IG CG
No. 183 179
Age, y 64.3 (5.1) 65.1 (4.9)
Sex, M/F, n 97/86 77/102
Weight, kg 89.7 (13.6) 86.7 (11.56)2
BMI, kg/m2 33.4 (30.8, 36.0) 32.9 (30.5, 35.6)
Waist circumference, cm 110.7 (9.8) 108.9 (9.55)
Diabetes (yes), % (n) 26.2 (48/135) 20.6 (37/142)
Hypercholesteremia, (no/yes), % (n) 94.5 (10/173) 93.8 (11/168)
Total cholesterol, mg/dL 203.0 (177.0, 224.5) 197.0 (172.5, 226.5)
LDL cholesterol, mg/dL 116.0 (94.5, 140.8) 115.0 (97.0, 139.5)
HDL cholesterol, mg/dL 46.0 (40.0, 57.0) 47.0 (42.0, 54.0)
Triglycerides, mg/dL 151.0 (55.3, 246.8) 152.0 (68.5, 235.5)
Glucose, mg/dL 104.0 (92.5, 118.0) 103.0 (94.0, 116.0)
Glycated hemoglobin, % 5.8 (5.6, 6.3) 5.8 (5.5, 6.3)
Physical activity, METs-min/wk 1627 (682, 3650) 1767 (839, 3308)
Energy intake, kcal/d 2546.5 (543.7) 2416.6 (514.7)
17-point Mediterranean adherence score 7.7 (2.1) 8 (2.4)
Smoking, n
 Current smoker 32 24
 Former smoker 65 68
 Never 85 87
 No data 1
Study center (Malaga/Reus), n 66/117 73/106

1Values expressed as Mean (SD) for normally distributed variables and Median (25%, 75% IQR) for non-normal distributions unless otherwise indicated. Chi-square, Wilcoxon, and t tests were conducted for categorical, nonnormal, and normally distributed variables, respectively. CG, control group; IG, intervention group; METs, Metabolic equivalent of task.

2Significant difference < 0.05.